These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16924234)

  • 21. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
    Shi YY; Small GW; Orlowski RZ
    Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
    Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA
    Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer.
    Santarpia L; El-Naggar AK; Cote GJ; Myers JN; Sherman SI
    J Clin Endocrinol Metab; 2008 Jan; 93(1):278-84. PubMed ID: 17989125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.
    Small GW; Shi YY; Higgins LS; Orlowski RZ
    Cancer Res; 2007 May; 67(9):4459-66. PubMed ID: 17483361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes.
    Bazuine M; Carlotti F; Tafrechi RS; Hoeben RC; Maassen JA
    Mol Endocrinol; 2004 Jul; 18(7):1697-707. PubMed ID: 15184525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpressed in anaplastic thyroid carcinoma-1 (OEATC-1) as a novel gene responsible for anaplastic thyroid carcinoma.
    Mizutani K; Onda M; Asaka S; Akaishi J; Miyamoto S; Yoshida A; Nagahama M; Ito K; Emi M
    Cancer; 2005 May; 103(9):1785-90. PubMed ID: 15789362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mechanism of the mitogen-activated protein kinase phosphatase-5 regulating the growth and invasion of a human prostate cancer cell line].
    He HY; Fang WG; Zheng J; You JF; Heng WJ; Li Y
    Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1812-7. PubMed ID: 14642090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MKP-8, a novel MAPK phosphatase that inhibits p38 kinase.
    Vasudevan SA; Skoko J; Wang K; Burlingame SM; Patel PN; Lazo JS; Nuchtern JG; Yang J
    Biochem Biophys Res Commun; 2005 May; 330(2):511-8. PubMed ID: 15796912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inverse Agonist of Estrogen-Related Receptor γ Enhances Sodium Iodide Symporter Function Through Mitogen-Activated Protein Kinase Signaling in Anaplastic Thyroid Cancer Cells.
    Singh TD; Jeong SY; Lee SW; Ha JH; Lee IK; Kim SH; Kim J; Cho SJ; Ahn BC; Lee J; Jeon YH
    J Nucl Med; 2015 Nov; 56(11):1690-6. PubMed ID: 26338896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apigenin induces c-Myc-mediated apoptosis in FRO anaplastic thyroid carcinoma cells.
    Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
    Mol Cell Endocrinol; 2013 Apr; 369(1-2):130-9. PubMed ID: 23376608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma.
    Salvatore G; Nappi TC; Salerno P; Jiang Y; Garbi C; Ugolini C; Miccoli P; Basolo F; Castellone MD; Cirafici AM; Melillo RM; Fusco A; Bittner ML; Santoro M
    Cancer Res; 2007 Nov; 67(21):10148-58. PubMed ID: 17981789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo.
    Iuliano R; Trapasso F; Le Pera I; Schepis F; Samà I; Clodomiro A; Dumon KR; Santoro M; Chiariotti L; Viglietto G; Fusco A
    Cancer Res; 2003 Feb; 63(4):882-6. PubMed ID: 12591742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer.
    De Falco V; Guarino V; Avilla E; Castellone MD; Salerno P; Salvatore G; Faviana P; Basolo F; Santoro M; Melillo RM
    Cancer Res; 2007 Dec; 67(24):11821-9. PubMed ID: 18089812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells.
    Hwang JH; Hwang JH; Chung HK; Kim DW; Hwang ES; Suh JM; Kim H; You KH; Kwon OY; Ro HK; Jo DY; Shong M
    J Clin Endocrinol Metab; 2003 Jan; 88(1):408-16. PubMed ID: 12519884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative genomic hybridization defines frequent loss on 16p in human anaplastic thyroid carcinoma.
    Komoike Y; Tamaki Y; Sakita I; Tomita N; Ohue M; Sekimoto M; Miyazaki M; Kadota M; Masuda N; Ooka M; Ohnishi T; Nakano Y; Kozaki T; Kobayashi T; Matsuura N; Ikeda T; Horii A; Monden M
    Int J Oncol; 1999 Jun; 14(6):1157-62. PubMed ID: 10339673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression, purification, and enzymatic characterization of the dual specificity mitogen-activated protein kinase phosphatase, MKP-4.
    Hong SB; Lubben TH; Dolliver CM; Petrolonis AJ; Roy RA; Li Z; Parsons TF; Li P; Xu H; Reilly RM; Trevillyan JM; Nichols AJ; Tummino PJ; Gant TG
    Bioorg Chem; 2005 Feb; 33(1):34-44. PubMed ID: 15668181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dusp26 phosphatase regulates mitochondrial respiration and oxidative stress and protects neuronal cell death.
    Eroglu B; Jin X; Deane S; Öztürk B; Ross OA; Moskophidis D; Mivechi NF
    Cell Mol Life Sci; 2022 Mar; 79(4):198. PubMed ID: 35313355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [SHP2 and MKP5 in P2Y purinergic receptor-mediated prostate cancer invasion].
    He HY; Zheng J; Li Y; Heng WJ; Fang WG
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):288-92. PubMed ID: 16181551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of novel dual-specificity phosphatase 26 inhibitors by a hybrid virtual screening approach based on pharmacophore and molecular docking.
    Ren JX; Cheng Z; Huang YX; Zhao JF; Guo P; Zou ZM; Xie Y
    Biomed Pharmacother; 2017 May; 89():376-385. PubMed ID: 28249240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atomic structure of dual-specificity phosphatase 26, a novel p53 phosphatase.
    Lokareddy RK; Bhardwaj A; Cingolani G
    Biochemistry; 2013 Feb; 52(5):938-48. PubMed ID: 23298255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.